ResearchUNITERAREApr 3
This is a research study looking for patients and families affected by rare diseases to share their thoughts and values about brain and nerve-related medical decisions. Researchers at St. Jude Children's Research Hospital want to understand what matters most to people living with rare diseases so they can make better ethical decisions in medical research and treatment. The study is now accepting participants and will start in April 2026.
WHY IT MATTERSThis study gives rare disease patients and caregivers a direct voice in shaping how medical ethics and brain-related research decisions are made — your input could influence future treatment guidelines and research practices.
ResearchPUBMEDApr 3
This research review looked at how mental health problems and rare diseases are connected, especially during the long process of getting diagnosed. Researchers found four main themes: patients struggling with hope and hopelessness, confusion about their identity, feeling alone or connected to others, and difficulty accessing mental health services that understand rare diseases. The study shows that mental health care and rare disease care need to work better together.
WHY IT MATTERSIf you or a loved one has a rare disease, this research validates that the emotional and mental health challenges you face during diagnosis and treatment are real and documented — and highlights why doctors should screen for depression and anxiety as part of rare disease care.
ResearchPUBMEDApr 3
Researchers tested whether artificial intelligence chatbots like ChatGPT could diagnose rare genetic diseases by comparing them to a traditional diagnostic tool called Exomiser. They tested seven different AI models on over 5,000 real patient cases. The study found that even the best AI chatbots were not as accurate as the existing diagnostic tool at identifying the correct disease.
WHY IT MATTERSIf you're waiting for a diagnosis for a rare genetic disease, this research shows that AI chatbots alone shouldn't replace traditional diagnostic tools—your doctor should continue using proven methods alongside any new technology.
ResearchPUBMEDApr 3
Researchers reviewed studies from the past 10 years about how artificial intelligence and connected care technologies can help patients with rare diseases, especially lysosomal storage disorders (LSDs)—conditions where the body can't break down certain substances properly. The review found that while these digital health tools show promise for helping doctors diagnose and manage these complex diseases, there are still big gaps in the research and not enough real-world examples of these technologies being used in patient care.
WHY IT MATTERSIf you have a lysosomal storage disorder, this research could lead to faster diagnosis, better remote monitoring through connected devices, and AI tools that help your doctors catch problems earlier—potentially improving your long-term care and quality of life.
ResearchBIORXIVApr 2
Researchers developed a new artificial intelligence system called GEN-KnowRD to help doctors recognize rare diseases faster and more accurately. Currently, patients with rare diseases wait years for a correct diagnosis because doctors don't have good tools to identify these uncommon conditions. This new AI system is designed to work better than previous attempts by using a smarter approach that doesn't require as much expert knowledge to keep updated.
WHY IT MATTERSFaster rare disease diagnosis could reduce the average diagnostic odyssey from years to months, allowing patients to access treatment and clinical trials earlier when interventions are most effective.
ResearchBIORXIVApr 2
Researchers discovered that mutations in a gene called THAP12 cause a severe type of childhood epilepsy called developmental and epileptic encephalopathy. Two siblings with this condition had two broken copies of the THAP12 gene (one from each parent), which stopped the gene from making enough of its protein. This finding helps explain why some children develop severe seizures early in life and could lead to better diagnosis and treatment options.
WHY IT MATTERSFamilies with children diagnosed with infantile spasms or Lennox-Gastaut syndrome now have a new genetic cause to test for, which could explain their child's condition and guide future treatment decisions.
ResearchCONGRESSApr 1
Researchers studied how life circumstances like poverty, access to healthcare, and education affect children with developmental delays and intellectual disabilities. They also looked at how long it takes families to get a diagnosis and whether genetic testing helps. The study suggests that where you live and your resources matter a lot in getting answers for why a child has developmental challenges.
WHY IT MATTERSThis research highlights that children from disadvantaged backgrounds face longer diagnostic journeys for developmental delays—meaning families may wait years longer to understand their child's condition and access support services.
ResearchPUBMEDApr 1
Researchers tested whether people could get genetic testing (genome sequencing) without always needing to see a genetics specialist first. They studied 313 people of all ages who had unexplained symptoms and could refer themselves or be referred by any doctor. The study found that people who referred themselves were just as likely to get a diagnosis as those referred by specialists. This suggests a new way to make genetic testing available to more people while still having genetics experts review the results.
WHY IT MATTERSIf this hybrid model works, patients with rare diseases could access genome sequencing faster and more easily without waiting for a genetics specialist appointment, potentially shortening the diagnostic odyssey that many rare disease patients experience.
ResearchPUBMEDApr 1
Researchers in Brazil studied dental care for children and teens with rare diseases at five specialized centers. They found that over 1,000 young patients with 244 different rare diseases received dental treatment, with blood-related diseases being the most common. On average, kids didn't see a dentist for the first time until age 8, and many had to travel far from home to get specialized dental care.
WHY IT MATTERSThis study shows that children with rare diseases often wait years before receiving dental care and face significant travel barriers—highlighting a critical gap in specialized dental services that families should advocate for in their own communities.
ResearchPUBMEDApr 1
Researchers reviewed 78 studies about early satiety (feeling full quickly after eating small amounts) in cancer patients. They found this symptom is common but often overlooked, and doctors don't have consistent ways to measure or describe it. The review shows there are big gaps in how we understand and treat this problem for cancer patients.
WHY IT MATTERSEarly satiety causes cancer patients to eat less and lose weight, which can weaken their ability to fight cancer and recover from treatment—but doctors rarely screen for or address this specific symptom.
ResearchPUBMEDApr 1
Scientists are developing a new way to study rare bone diseases using lab-grown bone tissue called organoids. Instead of only using animal tests or simple cell cultures, researchers can now grow tiny bone structures that act like real bones. This helps them understand why these diseases happen and test new treatments more accurately before trying them in patients.
WHY IT MATTERSFor patients with rare skeletal disorders, bone organoids could speed up the discovery of treatments by allowing researchers to test drugs on disease-specific bone tissue grown from patient cells, potentially leading to personalized medicine approaches.
ResearchPUBMEDApr 1
Researchers in Italy tested a new way to diagnose rare genetic diseases in children using whole genome sequencing—a test that reads all of a person's genetic code. Between 2018 and 2022, they studied 64 children with complex neurological problems that doctors couldn't figure out. This study shows whether this genetic test could help find answers faster for kids with mysterious rare diseases.
WHY IT MATTERSIf your child has unexplained neurological symptoms and multiple doctors haven't found a diagnosis, this research demonstrates that whole genome sequencing through healthcare systems may finally provide answers—potentially ending years of diagnostic uncertainty.
ResearchPUBMEDApr 1
Researchers in Turkey tested a new questionnaire called the Parental Needs Scale for Rare Diseases to measure what parents of children with rare diseases need most. The study included 264 parents and used statistical tests to make sure the questionnaire works well and gives consistent results. This tool can help doctors and support programs better understand and meet the needs of families dealing with rare diseases.
WHY IT MATTERSThis validated assessment tool enables healthcare systems to systematically identify and address the specific economic, emotional, and physical support needs of parents caring for children with rare diseases, potentially improving family quality of life and care outcomes.
ResearchPUBMEDApr 1
Researchers studied whether the amount of cancer in a patient's body before treatment affects how well two immunotherapy drugs work together. They looked at 722 patients with rare cancers who received nivolumab and ipilimumab (two drugs that help the immune system fight cancer). The study wanted to understand if patients with smaller tumors do better than those with larger tumors when treated with these combination drugs.
WHY IT MATTERSIf baseline tumor size predicts treatment response in rare cancers, doctors could better counsel patients on expected outcomes and identify which patients might benefit most from this dual immunotherapy approach before starting treatment.
ResearchPUBMEDApr 1
Scientists are developing a new technology called Digital Twins—computer models that act like virtual copies of individual patients. These virtual copies could help doctors diagnose rare childhood diseases faster and find better treatments by testing ideas on the computer before trying them on real patients. This is especially helpful for rare diseases because there aren't many patients to study, and it's hard to do traditional research on children.
WHY IT MATTERSDigital twins could speed up diagnosis and enable personalized treatment plans for children with rare diseases, potentially reducing the years of diagnostic delay that currently affects most pediatric rare disease patients.
ResearchCLINICALTRIALSMar 30
Researchers at Children's National completed a study testing a new support program for parents of children with rare diseases. The program, called Rare Group Problem Management Plus, brought parents together once a week for 5 weeks to help them manage stress, anxiety, and emotional challenges. The small study included 8 parents and focused on teaching practical coping skills in a group setting where everyone had similar experiences.
WHY IT MATTERSThis completed trial demonstrates that group-based support programs specifically designed for parents of children with rare conditions can address the significant mental health burden these families face, potentially offering a scalable model for other rare disease communities.
ResearchCLINICALTRIALSMar 30
This study is looking for 2,800 people to help researchers understand how being a caregiver affects a person's health and stress levels over time. The study includes caregivers of people with rare diseases like Batten disease, Tay-Sachs disease, and other inherited metabolic disorders, as well as caregivers of people with undiagnosed diseases. By learning more about caregiver stress, researchers hope to find ways to better support the millions of unpaid family caregivers in the U.S.
WHY IT MATTERSIf you or a family member care for someone with a rare inherited metabolic disorder, Batten disease, Tay-Sachs, or an undiagnosed disease, this study directly addresses the health challenges caregivers face and could lead to better support resources.
ResearchBIORXIVMar 30
Researchers studied how child abuse and accidental injuries affect DNA in different ways. They looked at saliva samples from children with injuries and used advanced technology to find specific DNA changes that appear in abused children but not in those with accidental injuries. This research could help doctors identify abuse cases earlier and understand how trauma affects children's bodies at a biological level.
WHY IT MATTERSIf validated, this epigenetic signature could provide doctors with an objective biological marker to help distinguish abuse from accidental injury in children presenting with traumatic injuries, potentially improving identification and intervention in suspected maltreatment cases.
ResearchBIORXIVMar 30
Scientists discovered that a gene called WAPL, which helps control how DNA is organized in cells, may cause a rare genetic disorder when it doesn't work properly. This is important because doctors previously thought only certain other genes in the same family could cause this type of disease. The researchers studied patients with this condition and did lab tests to prove WAPL is responsible for a genomic disorder affecting chromosome 10.
WHY IT MATTERSIf you or your child has developmental delays, intellectual disability, or birth defects without a genetic diagnosis, this discovery means WAPL gene testing could now identify the cause in previously undiagnosed patients.
ResearchBIORXIVMar 30
Researchers are testing whether artificial intelligence programs called large language models can help doctors decide which genetic tests to order for patients with rare diseases. Instead of doctors having to memorize complicated guidelines, the AI could read the patient's information and recommend whether a simple gene panel or a more complete genetic test would be best. This could make the process faster and more consistent across different hospitals.
WHY IT MATTERSIf this AI tool works well, patients with rare diseases could get the right genetic test recommended faster, potentially leading to quicker diagnoses and treatment decisions.